Spots Global Cancer Trial Database for anal squamous cell carcinoma
Every month we try and update this database with for anal squamous cell carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer | NCT05438836 | Anal Cancer Anal Carcinoma Anal Squamous C... | online adaptive... | 18 Years - | Herlev Hospital | |
| Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays | NCT02407561 | Rectal Adenocar... Anal Adenocarci... Anal Squamous C... | 18 Years - | Castle Biosciences Incorporated | ||
| 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer | NCT05130073 | Anal Squamous C... Stage 0 Anal Ca... Stage I Anal Ca... Stage II Anal C... Stage IIA Anal ... Stage IIB Anal ... Stage III Anal ... Stage IIIA Anal... Stage IIIB Anal... Stage IIIC Anal... | Computed Tomogr... Electronic Heal... Follow-Up Positron Emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer | NCT05130073 | Anal Squamous C... Stage 0 Anal Ca... Stage I Anal Ca... Stage II Anal C... Stage IIA Anal ... Stage IIB Anal ... Stage III Anal ... Stage IIIA Anal... Stage IIIB Anal... Stage IIIC Anal... | Computed Tomogr... Electronic Heal... Follow-Up Positron Emissi... | 18 Years - | M.D. Anderson Cancer Center | |
| Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer | NCT05438836 | Anal Cancer Anal Carcinoma Anal Squamous C... | online adaptive... | 18 Years - | Herlev Hospital | |
| Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers | NCT05582031 | Anal Squamous C... Colorectal Neop... Soft Tissue Sar... Malignant Pleur... Small Cell Lung... Castrate Resist... Neuroendocrine ... Gastroenteropan... | Regorafenib in ... | 18 Years - | Translational Research in Oncology | |
| Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection | NCT02437851 | Anal Squamous C... HIV Infection Stage 0 Anal Ca... Stage I Anal Ca... | Therapeutic Con... | 18 Years - | AIDS Malignancy Consortium | |
| Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays | NCT02407561 | Rectal Adenocar... Anal Adenocarci... Anal Squamous C... | 18 Years - | Castle Biosciences Incorporated | ||
| Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer | NCT04929028 | AIDS-Related An... Anal Basaloid S... Anal Canal Cloa... Anal Margin Squ... Anal Squamous C... HIV Infection Rectal Squamous... Stage I Anal Ca... Stage II Anal C... Stage II Rectal... Stage III Anal ... Stage III Recta... | Capecitabine Fluorouracil Intensity-Modul... Mitomycin Nivolumab | 18 Years - | National Cancer Institute (NCI) | |
| Oral Rigosertib for Squamous Cell Carcinoma | NCT01807546 | Head and Neck S... Anal Squamous C... Lung Squamous C... Cervical Squamo... Esophageal Squa... Skin Squamous C... Penile Squamous... | rigosertib | 18 Years - | Traws Pharma, Inc. | |
| Seville Cohort of People Living With HIV at Risk for Anal Cancer | NCT03713229 | Anal Squamous I... | Screening for a... | 18 Years - | Hospitales Universitarios Virgen del Rocío | |
| A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection | NCT05328765 | Anal Squamous C... HIV Infections | 18 Years - | Latin American Cooperative Oncology Group | ||
| Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients | NCT05374252 | Anal Canal Canc... Anal Squamous C... Anal Canal Canc... Anal Cancer | PD-1 inhibitor concurrent chem... | 18 Years - 75 Years | Sixth Affiliated Hospital, Sun Yat-sen University | |
| PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients | NCT05060471 | Anal Canal Canc... Anal Squamous C... Anal Cancer Anal Canal Canc... Anal Canal Canc... Anal Canal Canc... | Toripalimab | 18 Years - 75 Years | Sun Yat-sen University | |
| A Phase 1 Study in Participants With Advanced Cancer | NCT01115790 | Advanced Cancer Squamous Cell C... Carcinoma, Squa... Lung Squamous C... Anal Squamous C... Carcinoma, Non-... | Prexasertib | 18 Years - | Eli Lilly and Company | |
| Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer | NCT02560298 | Anal Basaloid C... Anal Canal Cloa... Anal Squamous C... Metastatic Anal... Recurrent Anal ... Stage IIIB Anal... Stage IV Anal C... | Capecitabine Carboplatin Cisplatin Fluorouracil Laboratory Biom... Paclitaxel Quality-of-Life... | 18 Years - | Eastern Cooperative Oncology Group | |
| MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach | NCT06050707 | Anal Squamous C... | Radiotherapy - ... Radiotherapy - ... Radiotherapy - ... Radiotherapy - ... | 18 Years - | University Health Network, Toronto | |
| Adaptive Radiation in Anal Cancer | NCT05838391 | Anal Squamous C... | Artificial Inte... Mitomycin-C 5-Fluorouracil Capecitabine | 18 Years - | Columbia University | |
| TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy | NCT04596033 | Melanoma Non-small Cell ... Squamous Cell C... Urothelial Carc... Renal Cell Carc... Small-cell Lung... Cutaneous Squam... Anal Squamous C... Merkel Cell Car... | GEN-011 IL-2 Fludarabine Cyclophosphamid... | 18 Years - | Genocea Biosciences, Inc. | |
| Vectibix for the Treatment of Anal Cancer | NCT01285778 | Anal Squamous C... | panitumumab, my... | 18 Years - | Grupo Espanol Multidisciplinario del Cancer Digestivo | |
| Oral Rigosertib for Squamous Cell Carcinoma | NCT01807546 | Head and Neck S... Anal Squamous C... Lung Squamous C... Cervical Squamo... Esophageal Squa... Skin Squamous C... Penile Squamous... | rigosertib | 18 Years - | Traws Pharma, Inc. | |
| Seville Cohort of People Living With HIV at Risk for Anal Cancer | NCT03713229 | Anal Squamous I... | Screening for a... | 18 Years - | Hospitales Universitarios Virgen del Rocío |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
